JP2011507915A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507915A5
JP2011507915A5 JP2010540046A JP2010540046A JP2011507915A5 JP 2011507915 A5 JP2011507915 A5 JP 2011507915A5 JP 2010540046 A JP2010540046 A JP 2010540046A JP 2010540046 A JP2010540046 A JP 2010540046A JP 2011507915 A5 JP2011507915 A5 JP 2011507915A5
Authority
JP
Japan
Prior art keywords
oxo
phenyl
ethoxy
carbonyl
pyrazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010540046A
Other languages
English (en)
Japanese (ja)
Other versions
JP5504171B2 (ja
JP2011507915A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/010572 external-priority patent/WO2009080226A2/en
Publication of JP2011507915A publication Critical patent/JP2011507915A/ja
Publication of JP2011507915A5 publication Critical patent/JP2011507915A5/ja
Application granted granted Critical
Publication of JP5504171B2 publication Critical patent/JP5504171B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010540046A 2007-12-26 2008-12-12 P2y12アンタゴニストとしてのヘテロサイクリックピラゾール−カルボキサミド Expired - Fee Related JP5504171B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07291627.3 2007-12-26
EP07291627 2007-12-26
PCT/EP2008/010572 WO2009080226A2 (en) 2007-12-26 2008-12-12 Heterocyclic pyrazole-carboxamides as p2y12 antagonists

Publications (3)

Publication Number Publication Date
JP2011507915A JP2011507915A (ja) 2011-03-10
JP2011507915A5 true JP2011507915A5 (cg-RX-API-DMAC7.html) 2012-02-02
JP5504171B2 JP5504171B2 (ja) 2014-05-28

Family

ID=39521970

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010540046A Expired - Fee Related JP5504171B2 (ja) 2007-12-26 2008-12-12 P2y12アンタゴニストとしてのヘテロサイクリックピラゾール−カルボキサミド

Country Status (4)

Country Link
US (1) US8426420B2 (cg-RX-API-DMAC7.html)
EP (1) EP2238128B1 (cg-RX-API-DMAC7.html)
JP (1) JP5504171B2 (cg-RX-API-DMAC7.html)
WO (1) WO2009080226A2 (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2225253B1 (en) 2007-11-29 2012-06-27 Actelion Pharmaceuticals Ltd. Phosphonic acid derivates and their use as p2y12 receptor antagonists
AR071653A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2-fenil-4-ciclopropil-pirimidina
AR071652A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2- fenil-piridina substituidos
CN102369197B (zh) 2009-04-08 2013-11-06 埃科特莱茵药品有限公司 作为adp受体拮抗剂的6-(3-氮杂-二环[3.1.0]己-3-基)-2-苯基-嘧啶
AU2010240527A1 (en) 2009-04-22 2011-12-01 Actelion Pharmaceuticals Ltd Thiazole derivatives and their use as P2Y12 receptor antagonists
TWI532725B (zh) * 2010-01-26 2016-05-11 賽諾菲阿凡提斯公司 經氧取代之3-雜芳醯基胺基-丙酸衍生物及其作為藥物之用途
TWI523844B (zh) 2011-01-26 2016-03-01 賽諾菲公司 經胺基取代之3-雜芳醯基胺基-丙酸衍生物及其作為藥物之用途
AR085013A1 (es) 2011-01-26 2013-08-07 Sanofi Aventis Derivados de acido 3-heteroaroilamino-propionico sustituidos y su uso como sustancias farmaceuticas
FR2974576B1 (fr) * 2011-04-29 2013-07-19 Sanofi Aventis Derives de n-[(1h-pyrazol-1-yl)aryl]-1h-indole ou 1h- indazole-3-carboxamide, leur preparation et leurs applications en therapeutique
MX339433B (es) 2011-07-26 2016-05-26 Sanofi Sa Derivados de acido 3 - tiazoloamino - propionico sustituidos y su uso como sustancias farmaceuticas.
DK2736888T3 (da) 2011-07-26 2016-02-01 Sanofi Sa 3-heteroaroylaminopropionsyrederivater og deres anvendelse som farmaceutika
EP2750676B1 (en) 2011-08-30 2018-01-10 University of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus
US20130123325A1 (en) 2011-11-14 2013-05-16 Sven Ruf Use of boceprevir and related compounds in atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases
US20130123276A1 (en) 2011-11-14 2013-05-16 Sven Ruf Use of telaprevir and related compounds in atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases
US9409895B2 (en) 2012-12-19 2016-08-09 Novartis Ag Autotaxin inhibitors
US9630945B2 (en) 2012-12-19 2017-04-25 Novartis Ag Autotaxin inhibitors
CN105051038B (zh) 2013-03-28 2018-08-03 赛诺菲 联芳基-丙酸衍生物及其作为药物的用途
EP2978747B1 (en) 2013-03-28 2017-04-19 Sanofi Biaryl-propionic acid derivatives and their use as pharmaceuticals
CN104109158A (zh) * 2013-04-16 2014-10-22 上海医药工业研究院 一种纯化利伐沙班的方法
EP3184095A1 (en) 2013-05-23 2017-06-28 IP Gesellschaft für Management mbH Administration units comprising polymorph 1 of 2-(2-methylamino-pyrimidin-4-yl]-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide
CN104418938B (zh) * 2013-08-28 2018-05-18 北京赛而生物药业有限公司 一种抗凝血化合物、其制备方法和用途、及包含其的药物组合物
US9231217B2 (en) * 2013-11-28 2016-01-05 Semiconductor Energy Laboratory Co., Ltd. Synthesis method of organometallic complex, synthesis method of pyrazine derivative, 5,6-diaryl-2-pyrazyl triflate, light-emitting element, light-emitting device, electronic device, and lighting device
AU2017331930B2 (en) 2016-09-22 2021-07-15 Viatris Asia Pacific Pte. Ltd. Crystalline forms
MX393334B (es) 2017-03-15 2025-03-24 Idorsia Pharmaceuticals Ltd Administración subcutánea de un antagonista del receptor p2y12.
US11696902B2 (en) 2018-08-14 2023-07-11 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US11344518B2 (en) 2018-08-14 2022-05-31 AltaThera Pharmaceuticals LLC Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame
US10512620B1 (en) 2018-08-14 2019-12-24 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US11610660B1 (en) 2021-08-20 2023-03-21 AltaThera Pharmaceuticals LLC Antiarrhythmic drug dosing methods, medical devices, and systems
US12396970B2 (en) 2021-08-20 2025-08-26 AltaThera Pharmaceuticals LLC Anti-arrhythmic compositions and methods
JP7684282B2 (ja) 2020-03-31 2025-05-27 田辺三菱製薬株式会社 ヒドロキシピロリジン誘導体およびその医薬用途
CN115429874A (zh) * 2022-09-20 2022-12-06 暨南大学 水蛭素靶向并抑制dpp4治疗糖尿病
CN119930579A (zh) * 2025-01-15 2025-05-06 四川轻化工大学 哌啶环类化合物及其合成方法、药学上可接受的盐与应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612359A (en) 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
US5621359A (en) * 1995-07-27 1997-04-15 Lucent Technologies Inc. Gain selection technique
TW536540B (en) 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
PE121699A1 (es) 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
ZA985247B (en) 1997-06-19 1999-12-17 Du Pont Merck Pharma Guanidine mimics as factor Xa inhibitors.
ES2318899T3 (es) 1998-07-06 2009-05-01 Bristol-Myers Squibb Company Bifenil sulfonamidas como antagonistas duales de los receptores de angiotensina y endotelina.
US6548529B1 (en) 1999-04-05 2003-04-15 Bristol-Myers Squibb Company Heterocyclic containing biphenyl aP2 inhibitors and method
WO2000076970A2 (en) 1999-06-14 2000-12-21 Eli Lilly And Company Serine protease inhibitors
MY125533A (en) 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
AR035216A1 (es) 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
US6861424B2 (en) * 2001-06-06 2005-03-01 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
KR100909141B1 (ko) 2001-09-21 2009-07-23 브리스톨-마이어스스퀴브컴파니 인자 Xa 억제제로서의 락탐-함유 화합물 및 그의 유도체
MXPA05006200A (es) * 2002-12-23 2005-08-19 Aventis Pharma Gmbh Derivados de pirazol como inhibidores del factor xa.
GB0309637D0 (en) * 2003-04-28 2003-06-04 Cancer Rec Tech Ltd Pyrazole compounds
AU2003249865A1 (en) 2003-06-24 2005-01-21 Actelion Pharmaceuticals Ltd Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors
TW200526641A (en) * 2003-12-26 2005-08-16 Daiichi Seiyaku Co Amidopyrazole derivatives
US7441581B2 (en) * 2005-03-10 2008-10-28 3M Innovative Properties Company Adhesive tape applicator
TW200640877A (en) * 2005-04-28 2006-12-01 Actelion Pharmaceuticals Ltd Pyrimidine derivatives

Similar Documents

Publication Publication Date Title
JP2011507915A5 (cg-RX-API-DMAC7.html)
US6627629B2 (en) N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity
TWI409261B (zh) 經取代之苯甲醯胺衍生物
AU2009314827B2 (en) Melanocortin receptor agonists
JP2006528940A5 (cg-RX-API-DMAC7.html)
DE602004006431D1 (de) Derivate von n-äheteroaryl(piperidin-2-yl)methylübenzamid, verfahren zu deren herstellung und deren anwendung in therapeutika
JP2016536333A5 (cg-RX-API-DMAC7.html)
JP2006525299A5 (cg-RX-API-DMAC7.html)
RU2013157374A (ru) Производное индазола и пирролопиридина и его фармацевтическое применение
AU2008258665B2 (en) Prolinamide derivatives as NK3 antagonists
RU2010106974A (ru) Ариловые эфиры пирролидина в качестве антагонистов рецепторов nk3
CA2623043A1 (en) Isoxazolo derivatives as gaba a alpha5 inverse agonists
CN1419541A (zh) 作为bax抑制剂的药物活性的吡咯烷衍生物
JP2016514709A5 (cg-RX-API-DMAC7.html)
ES2494065T3 (es) Derivados de pirrolidina
JP2014133739A5 (cg-RX-API-DMAC7.html)
SG174876A1 (en) Piperidine derivatives as nk3 receptor antagonists
RU2008149927A (ru) Производные 1-[(4-[ензоил(метил)амино]-3-(фенил)бутил]азетидина для лечения желудочно-кишечных расстройств
RU2561271C2 (ru) Производные пирролидина в качестве антагонистов рецептора nk-3
MX2010013311A (es) Derivados de pirrolidina como antagonistas del receptor de nk2.
CA2449578A1 (en) Pyrrolidine oxadiazole- and thiadiazole derivatives
RU2006100730A (ru) Цис-2, 4, 5-триарил-имидазолины
RU2664644C2 (ru) Новые производные тетразолона
RU2014136573A (ru) Новые производные пирролидина
AU2010215513A1 (en) Pyrrolidine derivatives as NK3 receptor antagonists